| Hypogonadism |
0 |
0.85 |
| Testosterone |
0 |
1 |
| Testosterone Therapy |
0 |
1 |
| Thromboembolism |
0 |
0.65 |
| Cardiovascular Risk Management |
0 |
0.52 |
| Renal Failure |
0 |
0.52 |
| Atrial Fibrillation |
0 |
0.48 |
| Cerebrovascular Accident |
0 |
0.42 |
| Arrhythmia |
0 |
0.39 |
| Prostate Cancer |
0 |
0.32 |
| Fractures |
0 |
0.27 |
| Renal Cell Carcinoma |
0 |
0.27 |
| Healthcare and Medical Technology |
0 |
0.26 |
| Wound Management |
0 |
0.26 |
| Pulmonary Embolism |
0 |
0.24 |
| Biologic Therapy |
0 |
0.21 |
| COVID-19 |
0 |
0.21 |
| Acute Kidney Injury |
0 |
0.19 |
| Heart |
0 |
0.15 |
| Washington |
0 |
0.12 |
| Clinical Guidelines |
0 |
0.09 |
| Infertility Male |
0 |
0.09 |
| Injury |
0 |
0.09 |
| Kidney |
0 |
0.09 |
| Myocardial Infarction (MI) |
0 |
0.09 |
| Anemia |
0 |
0.06 |
| Bone Density |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Embolism |
0 |
0.06 |
| Endocrine Society |
0 |
0.06 |
| Prostate |
0 |
0.06 |
| Transdermal |
0 |
0.06 |